Factors influencing recruitment to research: qualitative study of the experiences and perceptions of research teams

BMC Medical Research Methodology

Alison Metcalfe¹  Lisa Newington² 

[1] Florence Nightingale School of Nursing and Midwifery, King’s College London, James Clark Maxwell Building, SE1 8WA London, UK;NIHR Biomedical Research Centre, Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, Guy’s Hospital, SE1 9RT, London, UK

关键词: Qualitative;    Clinical research;    Participant recruitment;   

Others  :  866487
DOI  :  10.1186/1471-2288-14-10

 received in 2013-08-30, accepted in 2014-01-16,  发布年份 2014

【 摘 要 】

Background

Recruiting the required number of participants is vital to the success of clinical research and yet many studies fail to achieve their expected recruitment rate. Increasing research participation is a key agenda within the NHS and elsewhere, but the optimal methods of improving recruitment to clinical research remain elusive. The aim of this study was to identify the factors that researchers perceive as influential in the recruitment of participants to clinically focused research.

Methods

Semi-structured interviews were conducted with 11 individuals from three clinical research teams based in London. Sampling was a combination of convenience and purposive. The interviews were audio recorded, transcribed verbatim and analysed using the framework method to identify key themes.

Results

Four themes were identified as influential to recruitment: infrastructure, nature of the research, recruiter characteristics and participant characteristics. The main reason individuals participate in clinical research was believed to be altruism, while logistical issues were considered important for those who declined. Suggestions to improve recruitment included reducing participant burden, providing support for individuals who do not speak English, and forming collaborations with primary care to improve the identification of, and access to, potentially eligible participants.

Conclusions

Recruiting the target number of research participants was perceived as difficult, especially for clinical trials. New and diverse strategies to ensure that all potentially eligible patients are invited to participate may be beneficial and require further exploration in different settings. Establishing integrated clinical and academic teams with shared responsibilities for recruitment may also facilitate this process. Language barriers and long journey times were considered negative influences to recruitment; although more prominent, these issues are not unique to London and are likely to be important influences in other locations.

【 授权许可】

   
2014 Newington and Metcalfe; licensee BioMed Central Ltd.

【 参考文献 】

• [1]McDonald AM, Knight RC, Campbell MK, Entwistle VA, Grant AM, Cook JA, Elbourne DR, Francis D, Garcia J, Roberts I, et al.: What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials 2006, 7:9. BioMed Central Full Text
• [2]Equity and Excellence: Liberating the NHS http://www.gov.uk/government/publications/liberating-the-nhs-white-paper webcite
• [3]Treweek S, Lockhart P, Pitkethly M, Cook JA, Kjeldstrøm M, Johansen M, Taskila TK, Sullivan FM, Wilson S, Jackson C, et al.: Methods to improve recruitment to randomised controlled trials: Cochrane systematic review and meta-analysis. BMJ Open 2013, 3:e002360.
• [4]Brown WJ, Bryson L, Byles JE, Dobson AJ, Lee C, Mishra G, Schofield M: Women’s Health Australia: recruitment for a National Longitudinal Cohort Study. Women Health 1999, 28(1):23-40.
• [5]Dennis BP, Neese JB: Recruitment and retention of African American elders into community-based research: lessons learned. Arch Psychiatr Nurs 2000, 14(1):3-11.
• [6]Steinhauser KE, Clipp EC, Hays JC, Olsen M, Arnold R, Christakis NA, Lindquist JH, Tulsky JA: Identifying, recruiting, and retaining seriously-ill patients and their caregivers in longitudinal research. Palliat Med 2006, 20(8):745-754.
• [7]Seed M, Juarez M, Alnatour R: Improving recruitment and retention rates in preventive longitudinal research with adolescent mothers. J Child Adolesc Psychiatr Nurs 2009, 22(3):150-153.
• [8]Yancey AK, Ortega AN, Kumanyika SK: Effective recruitment and retention of minority research participants. Annu Rev Public Health 2006, 27(1):1-28.
• [9]Newington L, Metcalfe A: Researchers’ and clinicians’ perceptions of recruiting participants to clinical research: a thematic meta-synthesis. J Clin Med Res 2013. In Press
• [10]Cox K, McGarry J: Why patients don’t take part in cancer clinical trials: an overview of the literature. Eur J Cancer Care (Engl) 2003, 12(2):114-122.
• [11]Blanch DC, Rudd RE, Wright E, Gall V, Katz JN: Predictors of refusal during a multi-step recruitment process for a randomized controlled trial of arthritis education. Patient Educ Couns 2008, 73(2):280-285.
• [12]Madsen SM, Holm S, Davidsen B, Munkholm P, Schlichting P, Riis P: Ethical aspects of clinical trials: the attitudes of participants in two non-cancer trials. J Intern Med 2000, 248(6):463-474.
• [13]Verheggen FWSM, Nieman F, Jonkers R: Determinants of patient participation in clinical studies requiring informed consent: Why patients enter a clinical trial. Patient Educ Couns 1998, 35(2):111-125.
• [14]Webb MS: Focus groups as an intervention for low-income African-American smokers to promote participation in subsequent intervention studies. Res Nurs Health 2008, 31:141-151.
• [15]Gilbert H, Leurent B, Sutton S, Morris R, Alexis-Garsee C, Nazareth I: Factors predicting recruitment to a UK wide primary care smoking cessation study (the ESCAPE trial). Fam Pract 2012, 29(1):110-117.
• [16]Menon U, Gentry-Maharaj A, Ryan A, Sharma A, Burnell M, Hallett R, Lewis S, Lopez A, Godfrey K, Oram D, et al.: Recruitment to multicentre trials—lessons from UKCTOCS: descriptive study. BMJ 2008, 337:a2079.
• [17]Ritchie J, Spencer L: Qualitative data analysis for applied policy research. In Analyzing Qualitative Data. Edited by Bryman A, Burgess RG. London: Routledge; 1994:172-194.
• [18]Patterson S, Mairs H, Borschmann R: Successful recruitment to clinical trials: a phased approach to opening gates and building bridges. BMC Med Res Methodol 2011., 11(73) doi: 10.1186/1471-2288-11-73
• [19]Ziebland S, Featherstone K, Snowdon C, Barker K, Frost H, Fairbank J: Does it matter if clinicians recruiting for a trial don’t understand what the trial is really about? Qualitative study of surgeons’ experiences of participation in a pragmatic multi-centre RCT. Trials 2007, 8:4. BioMed Central Full Text
• [20]The handbook to the NHS Constitution http://www.gov.uk/government/publications/the-nhs-constitution-for-england webcite
• [21]Donovan JL, Peters TJ, Noble S, Powell P, Gillatt D, Oliver SE, Lane JA, Neal DE, Hamdy FC: Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study). J Clin Epidemiol 2003, 56(7):605-609.
• [22]Jenkins V, Fallowfied L: Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. Br J Cancer 2000, 82(11):1783-1788.
• [23]Quinn SC, Butler J III, Fryer CS, Garza MA, Kim KH, Ryan C, Thomas SB: Attributes of researchers and their strategies to recruit minority poulations: results of a national survey. Contemp Clin Trials 2012, 33:1231-1237.
• [24]Larkey LK, Staten LK, Ritenbaugh C, Hall RA, Buller DB, Bassford T, Altimari BR: Recruitment of hispanic women to the women’s health initiative: the case of Embajadoras in Arizona. Control Clin Trials 2002, 23(3):289-298.
• [25]Bean S, Silva DS: Betwixt & between: peer recruiter proximity in community-based research. Am J Bioeth 2010, 10(3):18-19.
• [26]Kruskal W, Mosteller F: Representative sampling, III: the current statistical literature. Int Stat Rev 1979, 47(3):245-265.
• [27]Halkoaho A, Pietila AM, Vahakangas K: Ethical aspects in placental perfusion studies: views of the researchers. Placenta 2011, 32(7):511-515.
• [28]Marko-Varga G: BioBanking - the holy grail of novel drug and diagnostic developments? J Clin Bioinformatics 2011, 1(1):14. BioMed Central Full Text
• [29]Day SJ, Altman DG: Blinding in clinical trials and other studies. BMJ 2000, 321(7259):504.
• [30]Büller HR, Halperin JL, Bounameaux H, Prins M: Double-blind studies are not always optimum for evaluation of a novel therapy: The case of new anticoagulants. J Thromb Haemost 2008, 6(2):227-229.
• [31]2011 Census: QS204EW Main language (detailed), unitary authorities in Wales (Release date 30 January 2013) [http://www.ons.gov.uk/ons/datasets-and-tables/index.html webcite]
• [32]Wendler D, Kington R, Madans J, Van Wye G, Christ-Schmidt H, Pratt LA, Brawley OW, Gross CP, Emanuel E: Are racial and ethnic minorities less willing to participate in health research? PLoS Med 2005, 3(2):e19.
• [33]Katz RV, Kegeles S, Kressin NR, Green B, Wang M, James SA, Russell SL, Claudio C: The Tuskegee legacy project: willingness of minorities to participate in biomedical research. J Health Care Poor Underserved 2006, 17(4):698-715.
• [34]Ness RB, Nelson DB, Kumanyika SK, Grisso JA: Evaluating minority recruitment into clinical studies: how good are the data? Ann Epidemiol 1997, 7(7):472-478.
• [35]Personal travel factsheet: commuting and business travel [http://www.gov.uk/government/uploads/system/uploads/attachment_data/file/49703/Commuting_and_business_travel_factsheet___April_2011.pdf webcite]